ArticleJournal for immunotherapy of cancer2024

Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy.

Haider Al-Janabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.